Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Qiagen N.V.
(NY:
QGEN
)
46.02
+0.82 (+1.81%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Qiagen N.V.
< Previous
1
2
3
Next >
QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Proposes Expansion of Supervisory Board
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System
May 05, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook
April 26, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to release results for Q1 2022 and hold Webcast
April 20, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
March 24, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Announces 20-F Annual Report Filing for 2021 Results
March 14, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year sales growth from non-COVID products
February 08, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
February 07, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s Commitment to LGBTQ+ and Gender Equality Recognized by Human Rights Campaign and Bloomberg Indexes
January 27, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance
January 25, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
January 19, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
January 18, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version
January 10, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations
January 07, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB
January 06, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
December 09, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19
December 02, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
November 29, 2021
From
QIAGEN N.V.
Via
Business Wire
Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases
November 09, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the...
Via
FinancialNewsMedia
Exposures
COVID-19
QIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050
November 08, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and BD Settle Patent Infringement Lawsuit
November 05, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021
November 03, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2
November 02, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Strengthens UK Footprint With Move to New Manchester Facilities
October 22, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to Release Results for Q3 2021 and First Nine Months of 2021
October 20, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions
October 19, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx
September 30, 2021
From
QIAGEN N.V.
Via
Business Wire
Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates
September 28, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates
September 14, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.